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Cystoscopy can be performed during hysterectomy for many
reasons, especially for suspicion of urologic injury (Ribeiro et al., 1999).
Though it is debated whether routine cystoscopy should be performed
at every hysterectomy, especially with regard to cost-effectiveness,
routine cystoscopy is still commonly performed.
Although not cost-effective in the general population, another poten-
tial use of routine cystoscopy is to evaluate for non-iatrogenic ureteral
abnormalities. Additionally, some surgeons at large academic institutions
take advantage of universal or selective post-operative cystoscopy as an
opportunity to teach trainees this important surgical skill. At the time of
hysterectomy, most urologic ﬁndings (e.g. hematuria or lack of ureteral
efﬂux) are due to bladder and/or ureteral injuries.Many of theseﬁndings
are due to idiopathic and self-resolving causes (Wilson and Merkur,
2008). However, urologic ﬁndings in certain gynecologic oncology
patients should raise concern about the possibility of synchronous
malignancies. For instance, Lynch syndrome (hereditary non-polyposis
colorectal cancer, HNPCC) is a rare but signiﬁcant risk factor for ureteral
transitional cell carcinoma (TCC). Whereas there have been reports of
intraoperatively-found incidental lymphoepithelial ureteral carcinomas
(Ma et al., 2008), a Pubmed search using the terms “transitional cell car-
cinoma” (or ureteral tumor), “incidental” and “hysterectomy” revealed
no prior reports of incidentally-found ureteral TCCs associated with
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A 73-year-old G5P5 Caucasian presented to her primary physician for
postmenopausal bleeding. Patient'sweightwas normal (bodymass index
24.7 kg/m2). Review of systems was otherwise unremarkable. Family
history yielded breast cancer in a maternal aunt and ovarian cancer in a
maternal cousin. Ultrasound showed an enlarged uterus and a 15.6 mm
endometrial stripe. Endometrial biopsy demonstrated a FIGO grade 1
endometrioid endometrial adenocarcinoma. She underwent total laparo-
scopic hysterectomy, bilateral salpingo-oophorectomy with pelvic and
paraaortic lymph node dissection. Routine cystoscopy after the procedure
revealed potent urinary efﬂux through the left ureteral oriﬁce, and a
potent and persistent hematuric jet from the right. An attempt at passing
a 5 Fr whistle-tip stent catheter through the distal right ureter was
unsuccessful. Urology was consulted and the decision was made to
explore the pelvis via a Pfannenstiel incision. The distal right pelvic ureter
was found to be non-dilated and non-injured. The patient was switched
to a ﬂuoroscopy-compatible bed, and retrograde ureteronephrogram
showed a ﬁlling defect at the L5 level. There was proximal dilatation
above the mid-right ureter with signiﬁcant tortuosity (Fig. 1). It was im-
possible to advance a retrograde ureteral stent. Therefore, an angiograph-
ic catheter was left in place distal to the lesion for repeat attempt by
interventional radiology. Postoperatively, an attempt was made to ascer-
tain history of prior hematuria, which the patient denied. Postoperative
computed tomography urogram conﬁrmed ﬁlling defects in the right
ureter, with associated proximal hydroureter and mild hydronephrosis
(Fig. 2). Despite distal ureteral access and digital subtraction radiologic
equipment, it remained impossible to advance a stent retrogradely. A
percutaneous nephrostomy tube was placed and brush sampling of the
mid-ureteral lesion yielded no evidence of atypia or malignancy.
Pathological evaluation of the endometrium revealed a stage IA
grade 1 endometrioid endometrial adenocarcinoma. The tumor in-
vaded superﬁcially with evidence of lymphovascular space inva-
sion, and 14 pelvic and periaortic lymph nodes were negative for
malignancy. The tumor showed loss of nuclear MSH6 expression
(Fig. 3A).
Due to strong clinical suspicion for ureteral neoplasm, the patient was
taken back to the operating room 8 weeks after her initial procedure and
underwent right subtotal ureterectomy (13.5 cm), Boari ﬂap reconstruc-
tion, and indwelling double-J ureteral stent placement. The specimen
contained a 4×0.8 cm solid, white-tan intraluminal mass extending
along the axis of the ureter. Microscopic exam conﬁrmed a low-grade
Fig. 1. Intraoperative retrograde ureteronephrogram demonstrating right-sided ﬁlling
defect accompanied by proximal ureteral dilation.
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muscularis propria (Fig. 3B). Margins of resection were negative. The
patient recovered uneventfully. A 2-week postoperative cystogram
showed postsurgical changes without evidence of leaks; the patient's
urethral catheter and stent were removed. At the time of this report, the
patient is receiving adjuvant vaginal cuff brachytherapy and MSH6
genotyping efforts are ongoing.Fig. 2. Computed tomography urogram conﬁrming the presence of right-sided ureteral
ﬁlling defect and hydronephrosis immediately proximal to the tip of a retrograde ure-
teral access catheter. Evaluation for enhancement is limited due to streak artifact and
volume averaging caused by the foreign body.Comment
Ureteral TCCs are extremely uncommon in the general population.
The lifetime risk of these lesions is greatly increased with a history of
Lynch syndrome (Watson et al., 2008).
A salient point from this case is that clinical suspicion of a urothelial
neoplasm is heightened with additional ﬁndings such as hematuria,
Lynch syndrome-associated cancers, and low BMI. Indeed, the mean
BMI of patients with microsatellite-unstable and Lynch-related tumors
is signiﬁcantly less than those with microsatellite-stable tumors (Cohn
et al., 2008). Thus, in this patient, endometrial cancerwith superimposed
hematuria raised concerns about an occult TCC in the setting of Lynch
syndrome.
There is lack of consensus regarding potential screening tools for
urologic neoplasms in patients with Lynch and other familial cancer
susceptibility syndromes. The National Comprehensive Cancer Network
(NCCN) guidelines on screening for different Lynch-associated cancers
are vague and lack supportive data. For urinary tract cancers, an annual
urinalysis is suggested. However, there is no deﬁnitive recommendation
regarding targeted age groups or potential use of screening urinary
cytology (Kohlmann and Gruber, 2004). The incidence of urinary tract
cancers, even in Lynch patients, is very lowunder the age of thirty. None-
theless, one study suggests that 21% of newly-diagnosed urothelial carci-
nomas may be associated with Lynch syndrome (Audenet et al., in
press). Further research is needed to deﬁne optimal screening guidelines,
to ensure multifaceted active surveillance in Lynch syndrome patients.Fig. 3. Panel A: Immunohistochemistry demonstrates lack of MSH6 protein (stromal
expression serves as internal positive control). Panel B: H&E, 40× photomicrograph
demonstrates muscle invasive ureteral papillary transitional cell carcinoma.
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clinical judgment becomes imperative. In the present case, despite incon-
clusive initial imaging and negative cytology the decision to actively
pursue workup for hematuria ended up revealing the TCC. Thus, contro-
versial butminimally-morbid procedures such as postoperative cystosco-
py after hysterectomy might provide additional beneﬁts to patients.
Taken together, this report underscores the need for being “clinically
alert” in suspecting rare cancers. Often, the notion of rare cancers is
dismissed and not further worked up when initial tests prove
unrevealing. Neglecting a thorough workup risks allowing potentially
early lesions to evolve (Fairley et al., 1998). The risk may supersede
cost-effectiveness in the management of this and other uncommon
tumors.Conﬂict of interest statement
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